Bridgebio Oncology Therapeutics, Inc. (BBOT)
4.70
-0.07
(-1.47%)
USD |
NASDAQ |
Sep 21, 10:30
Bridgebio Oncology Therapeutics Market Cap : 376.54M for Sept. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 382.15M |
| September 17, 2026 | 391.76M |
| September 16, 2026 | 381.35M |
| September 15, 2026 | 390.96M |
| September 14, 2026 | 404.58M |
| September 11, 2026 | 396.57M |
| September 10, 2026 | 442.23M |
| September 09, 2026 | 541.18M |
| September 08, 2026 | 709.82M |
| September 04, 2026 | 719.43M |
| September 03, 2026 | 713.02M |
| September 02, 2026 | 712.22M |
| September 01, 2026 | 706.61M |
| August 31, 2026 | 705.01M |
| August 28, 2026 | 700.21M |
| August 27, 2026 | 735.46M |
| August 26, 2026 | 741.86M |
| August 25, 2026 | 750.68M |
| August 24, 2026 | 732.25M |
| August 21, 2026 | 727.44M |
| August 20, 2026 | 727.44M |
| August 19, 2026 | 769.10M |
| August 18, 2026 | 717.03M |
| August 17, 2026 | 724.24M |
| August 14, 2026 | 725.84M |
| Date | Value |
|---|---|
| August 13, 2026 | 739.46M |
| August 12, 2026 | 754.68M |
| August 11, 2026 | 737.06M |
| August 10, 2026 | 743.47M |
| August 07, 2026 | 747.47M |
| August 06, 2026 | 703.18M |
| August 05, 2026 | 717.60M |
| August 04, 2026 | 710.39M |
| August 03, 2026 | 660.73M |
| July 31, 2026 | 647.92M |
| July 30, 2026 | 680.76M |
| July 29, 2026 | 659.53M |
| July 28, 2026 | 687.96M |
| July 27, 2026 | 700.78M |
| July 24, 2026 | 706.38M |
| July 23, 2026 | 698.38M |
| July 22, 2026 | 712.79M |
| July 21, 2026 | 698.38M |
| July 20, 2026 | 674.35M |
| July 17, 2026 | 685.56M |
| July 16, 2026 | 665.54M |
| July 15, 2026 | 673.55M |
| July 14, 2026 | 706.38M |
| July 13, 2026 | 682.36M |
| July 10, 2026 | 666.34M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 9.623B |
| Oncolytics Biotech, Inc. | 97.20M |
| Sangamo Therapeutics, Inc. | 60.03M |
| Sarepta Therapeutics, Inc. | 2.157B |
| Anixa Biosciences, Inc. | 94.42M |
Market Cap Related Metrics
| Price to Book Value | 1.165 |
| Price | 4.70 |
| Earnings Yield | -26.23K% |